Investor’s Toolkit: Key Ratios for Assessing Standard BioTools Inc (LAB)’s Performance

Published on December 30, 2024

12, 2023, KeyBanc Capital Markets started tracking the stock assigning a Overweight rating and target price of $4.KeyBanc Capital Markets

Continue reading on website
Other news

The IRS’s final “DeFi Broker” rule has been strongly opposed by the crypto industry. How likely is it that the Trump administration will revoke it?

December 30, 2024
Korve, head of regulation at a16z Crypto, a well known crypto enterprise capital fund, additionally posted on the X platform: “We at a16z

2024 Yearender: The music of exile: Cairo-based Sudanese musicians finding refuge in their art

December 30, 2024
Sudanese diaspora is by far the strongest in the context of music-making. To those communities, music serves not only as a form of artistic